Eli Samaha
CIK: 0001877589
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (19 total)
- Oct 1, 2026STGW
Stagwell Inc
Award(A)Direct2.5K shares at avg. $8.14$20K - Jul 7, 2026tbph
Theravance Biopharma, Inc.
Sale(S)Indirect5.6K shares at avg. $17.17$96K - Jul 6, 2026tbph
Theravance Biopharma, Inc.
Sale(S)Indirect1.4K shares at avg. $17.04$24K - Jul 1, 2026STGW
Stagwell Inc
Award(A)Direct2.7K shares at avg. $7.43$20K - Jul 1, 2026tbph
Theravance Biopharma, Inc.
Sale(S)Indirect37.8K shares at avg. $17.00$643K - Jun 30, 2026tbph
Theravance Biopharma, Inc.
Sale(S)Indirect25K shares at avg. $17.13$429K - Jun 29, 2026tbph
Theravance Biopharma, Inc.
Sale(S)Indirect273.9K shares at avg. $17.23$4.7M - Jun 11, 2026STGW
Stagwell Inc
Award(A)Direct23K shares- - Apr 1, 2026STGW
Stagwell Inc
Award(A)Direct3.2K shares at avg. $6.29$20K - Jan 2, 2026STGW
Stagwell Inc
Award(A)Direct4.1K shares at avg. $4.89$20K - Oct 1, 2025STGW
Stagwell Inc
Award(A)Direct3.6K shares at avg. $5.63$20K - Jul 1, 2025STGW
Stagwell Inc
Award(A)Direct4.4K shares at avg. $4.50$20K - Jun 12, 2025STGW
Stagwell Inc
Award(A)Direct30K shares- - Jun 5, 2025STGW
Stagwell Inc
Purchase(P)Indirect240K shares at avg. $4.43$1.1M - Jun 4, 2025STGW
Stagwell Inc
Purchase(P)Indirect425.8K shares at avg. $4.27$1.8M - May 9, 2025STGW
Stagwell Inc
Purchase(P)Indirect200.9K shares at avg. $4.76$956K - Apr 1, 2025STGW
Stagwell Inc
Award(A)Direct3.3K shares at avg. $6.05$20K - Jan 2, 2025STGW
Stagwell Inc
Award(A)Direct3K shares at avg. $6.58$20K - Oct 1, 2024STGW
Stagwell Inc
Award(A)Direct2.8K shares at avg. $7.02$20K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 1, 2026 |  STGW Stagwell Inc | Award(A) | 2,457 | $8.14 | $20,000 | Direct |
| Jul 7, 2026 |  tbph Theravance Biopharma, Inc. | Sale(S) | 5,564 | $17.17 | $95,541 | Indirect |
| Jul 6, 2026 | tbph Theravance Biopharma, Inc. | Sale(S) | 1,400 | $17.04 | $23,856 | Indirect |
| Jul 1, 2026 | STGW Stagwell Inc | Award(A) | 2,691 | $7.43 | $19,994 | Direct |
| Jul 1, 2026 | tbph Theravance Biopharma, Inc. | Sale(S) | 37,799 | $17.00 | $642,628 | Indirect |
| Jun 30, 2026 | tbph Theravance Biopharma, Inc. | Sale(S) | 25,027 | $17.13 | $428,788 | Indirect |
| Jun 29, 2026 | tbph Theravance Biopharma, Inc. | Sale(S) | 273,871 | $17.23 | $4,720,139 | Indirect |
| Jun 11, 2026 | STGW Stagwell Inc | Award(A) | 22,970 | - | $0 | Direct |
| Apr 1, 2026 | STGW Stagwell Inc | Award(A) | 3,180 | $6.29 | $20,002 | Direct |
| Jan 2, 2026 | STGW Stagwell Inc | Award(A) | 4,090 | $4.89 | $20,000 | Direct |
| Oct 1, 2025 | STGW Stagwell Inc | Award(A) | 3,552 | $5.63 | $19,998 | Direct |
| Jul 1, 2025 | STGW Stagwell Inc | Award(A) | 4,444 | $4.50 | $19,998 | Direct |
| Jun 12, 2025 | STGW Stagwell Inc | Award(A) | 30,000 | - | - | Direct |
| Jun 5, 2025 | STGW Stagwell Inc | Purchase(P) | 240,000 | $4.43 | $1,063,200 | Indirect |
| Jun 4, 2025 | STGW Stagwell Inc | Purchase(P) | 425,757 | $4.27 | $1,817,982 | Indirect |
| May 9, 2025 | STGW Stagwell Inc | Purchase(P) | 200,903 | $4.76 | $956,318 | Indirect |
| Apr 1, 2025 | STGW Stagwell Inc | Award(A) | 3,305 | $6.05 | $19,995 | Direct |
| Jan 2, 2025 | STGW Stagwell Inc | Award(A) | 3,040 | $6.58 | $20,003 | Direct |
| Oct 1, 2024 | STGW Stagwell Inc | Award(A) | 2,849 | $7.02 | $20,000 | Direct |
1-19 of 19 transactions
About Samaha Eli
Samaha Eli (SEC CIK 0001877589) files insider reports with the SEC as Director of Stagwell Inc (STGW) and 10% Owner of Theravance Biopharma, Inc. (TBPH).
Signal8 holds 15 ownership filings by Samaha Eli, all Form 4s, filed between Oct 3, 2024 and Oct 2, 2026. Those filings report 19 transactions, from Oct 1, 2024 to Oct 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Samaha Eli's filings is in NEW YORK, NY.
Recent filings by Samaha Eli
- Oct 1, 2026: Grant or award of STGW shares (Form 4, code A).
- Jul 7, 2026: Open-market sale of TBPH shares (Form 4, code S).
- Jul 6, 2026: Open-market sale of TBPH shares (Form 4, code S).
- Jul 1, 2026: Grant or award of STGW shares (Form 4, code A).
- Jul 1, 2026: Open-market sale of TBPH shares (Form 4, code S).
Other insiders filing for Stagwell Inc (STGW)
- Penn Mark Jeffery, Chief Executive Officer
- Vaughan Brandt A., Director
- KAPLAN BETH J, Director
- Lanuto Frank P
- SLATER RODNEY E, Director
- SIMON IRWIN D, Director